img

Global FIS1 Antibody Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical

Publisher : MRA | Format : PDF

Global FIS1 Antibody Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal FIS1 Antibody Market
Global FIS1 Antibody market is expected to reach to US$ million in 2023, with a positive growth of %, compared with US$ million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, FIS1 Antibody industry is evaluated to reach US$ million in 2033. The CAGR will be % during 2023 to 2033.
Globally, FIS1 Antibody key companies include Merck, Bioss, Thermo Fisher Scientific, Novus Biologicals, GeneTex, Enzo Life Sciences, Inc., RayBiotech, LifeSpan BioSciences and Leading Biology, etc. Merck, Bioss, Thermo Fisher Scientific are top 3 players and held % share in total in 2022.
When considering the consumption regions, % revenue of FIS1 Antibody were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the share will be % in 2033. Moreover, China, plays a key role in the whole FIS1 Antibody market and estimated to attract more attentions from industry insiders and investors.
FIS1 Antibody can be divided into Monoclonal and Polyclonal, etc. Monoclonal is the mainstream product in the market, accounting for % revenue share globally in 2022 and the proportion will be % in 2033.
FIS1 Antibody is widely used in various fields, such as Immunochemistry (IHC), Immunofluorescence (IF), Immunoprecipitation (IP) and Western Blot (WB), etc. Immunochemistry (IHC) provides greatest supports to the FIS1 Antibody industry development. In 2022, global % revenue of FIS1 Antibody went into Immunochemistry (IHC) filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global FIS1 Antibody market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global FIS1 Antibody market with multiple angles. Items like regional revenue from 2018 to 2033 and companies’ revenue and gross margin from 2018 to 2023 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Merck
Bioss
Thermo Fisher Scientific
Novus Biologicals
GeneTex
Enzo Life Sciences, Inc.
RayBiotech
LifeSpan BioSciences
Leading Biology
ProSci
Abcam
OriGene Technologies
NSJ Bioreagents
Affinity Biosciences
Biobyt
Jingjie PTM BioLab
Beijing Solarbio
Segment by Type
Monoclonal
Polyclonal

Segment by Application


Immunochemistry (IHC)
Immunofluorescence (IF)
Immunoprecipitation (IP)
Western Blot (WB)
ELISA
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2033
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2033 globally
Chapter 5Product revenue analysis by application from 2018 to 2033 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2033 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product revenue analysis by type and application from 2018 to 2033 in Europe. Product revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product revenue analysis by type and application from 2018 to 2033 in China. Product revenue analysis of China from 2018 to 2033
Chapter 9Product revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Companies’ outline, covering company’s basic information, major business, FIS1 Antibody introduction, etc. FIS1 Antibody Revenue and Gross Margin of each company from 2018 to 2023
Chapter 12MRAResearch’s Conclusions of FIS1 Antibody
Chapter 13Methodology and Data Sources adopted by MRAResearch

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global FIS1 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2033
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global FIS1 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2033
1.3.2 Immunochemistry (IHC)
1.3.3 Immunofluorescence (IF)
1.3.4 Immunoprecipitation (IP)
1.3.5 Western Blot (WB)
1.3.6 ELISA
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global FIS1 Antibody Market Perspective (2018-2033)
2.2 Global FIS1 Antibody Growth Trends by Region
2.2.1 FIS1 Antibody Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 FIS1 Antibody Historic Market Size by Region (2018-2023)
2.2.3 FIS1 Antibody Forecasted Market Size by Region (2024-2033)
2.3 FIS1 Antibody Market Dynamics
2.3.1 FIS1 Antibody Industry Trends
2.3.2 FIS1 Antibody Market Drivers
2.3.3 FIS1 Antibody Market Challenges
2.3.4 FIS1 Antibody Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue FIS1 Antibody by Players
3.1.1 Global FIS1 Antibody Revenue by Players (2018-2023)
3.1.2 Global FIS1 Antibody Revenue Market Share by Players (2018-2023)
3.2 Global FIS1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of FIS1 Antibody, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global FIS1 Antibody Market Concentration Ratio
3.4.1 Global FIS1 Antibody Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by FIS1 Antibody Revenue in 2022
3.5 Global Key Players of FIS1 Antibody Head office and Area Served
3.6 Global Key Players of FIS1 Antibody, Product and Application
3.7 Global Key Players of FIS1 Antibody, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 FIS1 Antibody Breakdown Data by Type
4.1 Global FIS1 Antibody Historic Market Size by Type (2018-2023)
4.2 Global FIS1 Antibody Forecasted Market Size by Type (2024-2033)
5 FIS1 Antibody Breakdown Data by Application
5.1 Global FIS1 Antibody Historic Market Size by Application (2018-2023)
5.2 Global FIS1 Antibody Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America FIS1 Antibody Market Size (2018-2033)
6.2 North America FIS1 Antibody Market Size by Type
6.2.1 North America FIS1 Antibody Market Size by Type (2018-2023)
6.2.2 North America FIS1 Antibody Market Size by Type (2024-2033)
6.2.3 North America FIS1 Antibody Market Share by Type (2018-2033)
6.3 North America FIS1 Antibody Market Size by Application
6.3.1 North America FIS1 Antibody Market Size by Application (2018-2023)
6.3.2 North America FIS1 Antibody Market Size by Application (2024-2033)
6.3.3 North America FIS1 Antibody Market Share by Application (2018-2033)
6.4 North America FIS1 Antibody Market Size by Country
6.4.1 North America FIS1 Antibody Market Size by Country: 2018 VS 2022 VS 2033
6.4.2 North America FIS1 Antibody Market Size by Country (2018-2023)
6.4.3 North America FIS1 Antibody Market Size by Country (2024-2033)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe FIS1 Antibody Market Size (2018-2033)
7.2 Europe FIS1 Antibody Market Size by Type
7.2.1 Europe FIS1 Antibody Market Size by Type (2018-2023)
7.2.2 Europe FIS1 Antibody Market Size by Type (2024-2033)
7.2.3 Europe FIS1 Antibody Market Share by Type (2018-2033)
7.3 Europe FIS1 Antibody Market Size by Application
7.3.1 Europe FIS1 Antibody Market Size by Application (2018-2023)
7.3.2 Europe FIS1 Antibody Market Size by Application (2024-2033)
7.3.3 Europe FIS1 Antibody Market Share by Application (2018-2033)
7.4 Europe FIS1 Antibody Market Size by Country
7.4.1 Europe FIS1 Antibody Market Size by Country: 2018 VS 2022 VS 2033
7.4.2 Europe FIS1 Antibody Market Size by Country (2018-2023)
7.4.3 Europe FIS1 Antibody Market Size by Country (2024-2033)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China FIS1 Antibody Market Size (2018-2033)
8.2 China FIS1 Antibody Market Size by Type
8.2.1 China FIS1 Antibody Market Size by Type (2018-2023)
8.2.2 China FIS1 Antibody Market Size by Type (2024-2033)
8.2.3 China FIS1 Antibody Market Share by Type (2018-2033)
8.3 China FIS1 Antibody Market Size by Application
8.3.1 China FIS1 Antibody Market Size by Application (2018-2023)
8.3.2 China FIS1 Antibody Market Size by Application (2024-2033)
8.3.3 China FIS1 Antibody Market Share by Application (2018-2033)
9 Asia (excluding China)
9.1 Asia FIS1 Antibody Market Size (2018-2033)
9.2 Asia FIS1 Antibody Market Size by Type
9.2.1 Asia FIS1 Antibody Market Size by Type (2018-2023)
9.2.2 Asia FIS1 Antibody Market Size by Type (2024-2033)
9.2.3 Asia FIS1 Antibody Market Share by Type (2018-2033)
9.3 Asia FIS1 Antibody Market Size by Application
9.3.1 Asia FIS1 Antibody Market Size by Application (2018-2023)
9.3.2 Asia FIS1 Antibody Market Size by Application (2024-2033)
9.3.3 Asia FIS1 Antibody Market Share by Application (2018-2033)
9.4 Asia FIS1 Antibody Market Size by Region
9.4.1 Asia FIS1 Antibody Market Size by Region: 2018 VS 2022 VS 2033
9.4.2 Asia FIS1 Antibody Market Size by Region (2018-2023)
9.4.3 Asia FIS1 Antibody Market Size by Region (2024-2033)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America FIS1 Antibody Market Size (2018-2033)
10.2 Middle East, Africa, and Latin America FIS1 Antibody Market Size by Type
10.2.1 Middle East, Africa, and Latin America FIS1 Antibody Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America FIS1 Antibody Market Size by Type (2024-2033)
10.2.3 Middle East, Africa, and Latin America FIS1 Antibody Market Share by Type (2018-2033)
10.3 Middle East, Africa, and Latin America FIS1 Antibody Market Size by Application
10.3.1 Middle East, Africa, and Latin America FIS1 Antibody Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America FIS1 Antibody Market Size by Application (2024-2033)
10.3.3 Middle East, Africa, and Latin America FIS1 Antibody Market Share by Application (2018-2033)
10.4 Middle East, Africa, and Latin America FIS1 Antibody Market Size by Country
10.4.1 Middle East, Africa, and Latin America FIS1 Antibody Market Size by Country: 2018 VS 2022 VS 2033
10.4.2 Middle East, Africa, and Latin America FIS1 Antibody Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America FIS1 Antibody Market Size by Country (2024-2033)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck FIS1 Antibody Introduction
11.1.4 Merck Revenue in FIS1 Antibody Business (2018-2023)
11.1.5 Merck Recent Developments
11.2 Bioss
11.2.1 Bioss Company Details
11.2.2 Bioss Business Overview
11.2.3 Bioss FIS1 Antibody Introduction
11.2.4 Bioss Revenue in FIS1 Antibody Business (2018-2023)
11.2.5 Bioss Recent Developments
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Details
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific FIS1 Antibody Introduction
11.3.4 Thermo Fisher Scientific Revenue in FIS1 Antibody Business (2018-2023)
11.3.5 Thermo Fisher Scientific Recent Developments
11.4 Novus Biologicals
11.4.1 Novus Biologicals Company Details
11.4.2 Novus Biologicals Business Overview
11.4.3 Novus Biologicals FIS1 Antibody Introduction
11.4.4 Novus Biologicals Revenue in FIS1 Antibody Business (2018-2023)
11.4.5 Novus Biologicals Recent Developments
11.5 GeneTex
11.5.1 GeneTex Company Details
11.5.2 GeneTex Business Overview
11.5.3 GeneTex FIS1 Antibody Introduction
11.5.4 GeneTex Revenue in FIS1 Antibody Business (2018-2023)
11.5.5 GeneTex Recent Developments
11.6 Enzo Life Sciences, Inc.
11.6.1 Enzo Life Sciences, Inc. Company Details
11.6.2 Enzo Life Sciences, Inc. Business Overview
11.6.3 Enzo Life Sciences, Inc. FIS1 Antibody Introduction
11.6.4 Enzo Life Sciences, Inc. Revenue in FIS1 Antibody Business (2018-2023)
11.6.5 Enzo Life Sciences, Inc. Recent Developments
11.7 RayBiotech
11.7.1 RayBiotech Company Details
11.7.2 RayBiotech Business Overview
11.7.3 RayBiotech FIS1 Antibody Introduction
11.7.4 RayBiotech Revenue in FIS1 Antibody Business (2018-2023)
11.7.5 RayBiotech Recent Developments
11.8 LifeSpan BioSciences
11.8.1 LifeSpan BioSciences Company Details
11.8.2 LifeSpan BioSciences Business Overview
11.8.3 LifeSpan BioSciences FIS1 Antibody Introduction
11.8.4 LifeSpan BioSciences Revenue in FIS1 Antibody Business (2018-2023)
11.8.5 LifeSpan BioSciences Recent Developments
11.9 Leading Biology
11.9.1 Leading Biology Company Details
11.9.2 Leading Biology Business Overview
11.9.3 Leading Biology FIS1 Antibody Introduction
11.9.4 Leading Biology Revenue in FIS1 Antibody Business (2018-2023)
11.9.5 Leading Biology Recent Developments
11.10 ProSci
11.10.1 ProSci Company Details
11.10.2 ProSci Business Overview
11.10.3 ProSci FIS1 Antibody Introduction
11.10.4 ProSci Revenue in FIS1 Antibody Business (2018-2023)
11.10.5 ProSci Recent Developments
11.11 Abcam
11.11.1 Abcam Company Details
11.11.2 Abcam Business Overview
11.11.3 Abcam FIS1 Antibody Introduction
11.11.4 Abcam Revenue in FIS1 Antibody Business (2018-2023)
11.11.5 Abcam Recent Developments
11.12 OriGene Technologies
11.12.1 OriGene Technologies Company Details
11.12.2 OriGene Technologies Business Overview
11.12.3 OriGene Technologies FIS1 Antibody Introduction
11.12.4 OriGene Technologies Revenue in FIS1 Antibody Business (2018-2023)
11.12.5 OriGene Technologies Recent Developments
11.13 NSJ Bioreagents
11.13.1 NSJ Bioreagents Company Details
11.13.2 NSJ Bioreagents Business Overview
11.13.3 NSJ Bioreagents FIS1 Antibody Introduction
11.13.4 NSJ Bioreagents Revenue in FIS1 Antibody Business (2018-2023)
11.13.5 NSJ Bioreagents Recent Developments
11.14 Affinity Biosciences
11.14.1 Affinity Biosciences Company Details
11.14.2 Affinity Biosciences Business Overview
11.14.3 Affinity Biosciences FIS1 Antibody Introduction
11.14.4 Affinity Biosciences Revenue in FIS1 Antibody Business (2018-2023)
11.14.5 Affinity Biosciences Recent Developments
11.15 Biobyt
11.15.1 Biobyt Company Details
11.15.2 Biobyt Business Overview
11.15.3 Biobyt FIS1 Antibody Introduction
11.15.4 Biobyt Revenue in FIS1 Antibody Business (2018-2023)
11.15.5 Biobyt Recent Developments
11.16 Jingjie PTM BioLab
11.16.1 Jingjie PTM BioLab Company Details
11.16.2 Jingjie PTM BioLab Business Overview
11.16.3 Jingjie PTM BioLab FIS1 Antibody Introduction
11.16.4 Jingjie PTM BioLab Revenue in FIS1 Antibody Business (2018-2023)
11.16.5 Jingjie PTM BioLab Recent Developments
11.17 Beijing Solarbio
11.17.1 Beijing Solarbio Company Details
11.17.2 Beijing Solarbio Business Overview
11.17.3 Beijing Solarbio FIS1 Antibody Introduction
11.17.4 Beijing Solarbio Revenue in FIS1 Antibody Business (2018-2023)
11.17.5 Beijing Solarbio Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global FIS1 Antibody Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2033
Table 2. Key Players of Monoclonal
Table 3. Key Players of Polyclonal
Table 4. Global FIS1 Antibody Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2033
Table 5. Global FIS1 Antibody Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 6. Global FIS1 Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global FIS1 Antibody Market Share by Region (2018-2023)
Table 8. Global FIS1 Antibody Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 9. Global FIS1 Antibody Market Share by Region (2024-2033)
Table 10. FIS1 Antibody Market Trends
Table 11. FIS1 Antibody Market Drivers
Table 12. FIS1 Antibody Market Challenges
Table 13. FIS1 Antibody Market Restraints
Table 14. Global FIS1 Antibody Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global FIS1 Antibody Revenue Share by Players (2018-2023)
Table 16. Global Top FIS1 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in FIS1 Antibody as of 2022)
Table 17. Global FIS1 Antibody Industry Ranking 2021 VS 2022 VS 2023
Table 18. Global 5 Largest Players Market Share by FIS1 Antibody Revenue (CR5 and HHI) & (2018-2023)
Table 19. Global Key Players of FIS1 Antibody, Headquarters and Area Served
Table 20. Global Key Players of FIS1 Antibody, Product and Application
Table 21. Global Key Players of FIS1 Antibody, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global FIS1 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global FIS1 Antibody Revenue Market Share by Type (2018-2023)
Table 25. Global FIS1 Antibody Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 26. Global FIS1 Antibody Revenue Market Share by Type (2024-2033)
Table 27. Global FIS1 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global FIS1 Antibody Revenue Share by Application (2018-2023)
Table 29. Global FIS1 Antibody Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 30. Global FIS1 Antibody Revenue Share by Application (2024-2033)
Table 31. North America FIS1 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 32. North America FIS1 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 33. North America FIS1 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 34. North America FIS1 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 35. North America FIS1 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 36. North America FIS1 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 37. North America FIS1 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 38. Europe FIS1 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 39. Europe FIS1 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 40. Europe FIS1 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 41. Europe FIS1 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 42. Europe FIS1 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 43. Europe FIS1 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 44. Europe FIS1 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 45. China FIS1 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 46. China FIS1 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 47. China FIS1 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 48. China FIS1 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 49. Asia FIS1 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 50. Asia FIS1 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 51. Asia FIS1 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 52. Asia FIS1 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 53. Asia FIS1 Antibody Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2033
Table 54. Asia FIS1 Antibody Market Size by Region (2018-2023) & (US$ Million)
Table 55. Asia FIS1 Antibody Market Size by Region (2024-2033) & (US$ Million)
Table 56. Middle East, Africa, and Latin America FIS1 Antibody Market Size by Type (2018-2023) & (US$ Million)
Table 57. Middle East, Africa, and Latin America FIS1 Antibody Market Size by Type (2024-2033) & (US$ Million)
Table 58. Middle East, Africa, and Latin America FIS1 Antibody Market Size by Application (2018-2023) & (US$ Million)
Table 59. Middle East, Africa, and Latin America FIS1 Antibody Market Size by Application (2024-2033) & (US$ Million)
Table 60. Middle East, Africa, and Latin America FIS1 Antibody Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2033
Table 61. Middle East, Africa, and Latin America FIS1 Antibody Market Size by Country (2018-2023) & (US$ Million)
Table 62. Middle East, Africa, and Latin America FIS1 Antibody Market Size by Country (2024-2033) & (US$ Million)
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck FIS1 Antibody Product
Table 66. Merck Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 67. Merck Recent Developments
Table 68. Bioss Company Details
Table 69. Bioss Business Overview
Table 70. Bioss FIS1 Antibody Product
Table 71. Bioss Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 72. Bioss Recent Developments
Table 73. Thermo Fisher Scientific Company Details
Table 74. Thermo Fisher Scientific Business Overview
Table 75. Thermo Fisher Scientific FIS1 Antibody Product
Table 76. Thermo Fisher Scientific Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 77. Thermo Fisher Scientific Recent Developments
Table 78. Novus Biologicals Company Details
Table 79. Novus Biologicals Business Overview
Table 80. Novus Biologicals FIS1 Antibody Product
Table 81. Novus Biologicals Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 82. Novus Biologicals Recent Developments
Table 83. GeneTex Company Details
Table 84. GeneTex Business Overview
Table 85. GeneTex FIS1 Antibody Product
Table 86. GeneTex Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 87. GeneTex Recent Developments
Table 88. Enzo Life Sciences, Inc. Company Details
Table 89. Enzo Life Sciences, Inc. Business Overview
Table 90. Enzo Life Sciences, Inc. FIS1 Antibody Product
Table 91. Enzo Life Sciences, Inc. Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 92. Enzo Life Sciences, Inc. Recent Developments
Table 93. RayBiotech Company Details
Table 94. RayBiotech Business Overview
Table 95. RayBiotech FIS1 Antibody Product
Table 96. RayBiotech Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 97. RayBiotech Recent Developments
Table 98. LifeSpan BioSciences Company Details
Table 99. LifeSpan BioSciences Business Overview
Table 100. LifeSpan BioSciences FIS1 Antibody Product
Table 101. LifeSpan BioSciences Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 102. LifeSpan BioSciences Recent Developments
Table 103. Leading Biology Company Details
Table 104. Leading Biology Business Overview
Table 105. Leading Biology FIS1 Antibody Product
Table 106. Leading Biology Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 107. Leading Biology Recent Developments
Table 108. ProSci Company Details
Table 109. ProSci Business Overview
Table 110. ProSci FIS1 Antibody Product
Table 111. ProSci Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 112. ProSci Recent Developments
Table 113. Abcam Company Details
Table 114. Abcam Business Overview
Table 115. Abcam FIS1 Antibody Product
Table 116. Abcam Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 117. Abcam Recent Developments
Table 118. OriGene Technologies Company Details
Table 119. OriGene Technologies Business Overview
Table 120. OriGene Technologies FIS1 Antibody Product
Table 121. OriGene Technologies Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 122. OriGene Technologies Recent Developments
Table 123. NSJ Bioreagents Company Details
Table 124. NSJ Bioreagents Business Overview
Table 125. NSJ Bioreagents FIS1 Antibody Product
Table 126. NSJ Bioreagents Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 127. NSJ Bioreagents Recent Developments
Table 128. Affinity Biosciences Company Details
Table 129. Affinity Biosciences Business Overview
Table 130. Affinity Biosciences FIS1 Antibody Product
Table 131. Affinity Biosciences Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 132. Affinity Biosciences Recent Developments
Table 133. Biobyt Company Details
Table 134. Biobyt Business Overview
Table 135. Biobyt FIS1 Antibody Product
Table 136. Biobyt Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 137. Biobyt Recent Developments
Table 138. Jingjie PTM BioLab Company Details
Table 139. Jingjie PTM BioLab Business Overview
Table 140. Jingjie PTM BioLab FIS1 Antibody Product
Table 141. Jingjie PTM BioLab Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 142. Jingjie PTM BioLab Recent Developments
Table 143. Beijing Solarbio Company Details
Table 144. Beijing Solarbio Business Overview
Table 145. Beijing Solarbio FIS1 Antibody Product
Table 146. Beijing Solarbio Revenue in FIS1 Antibody Business (2018-2023) & (US$ Million)
Table 147. Beijing Solarbio Recent Developments
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global FIS1 Antibody Market Size Growth Rate by Type, 2018 VS 2022 VS 2033 (US$ Million)
Figure 2. Global FIS1 Antibody Market Share by Type: 2022 VS 2033
Figure 3. Monoclonal Features
Figure 4. Polyclonal Features
Figure 5. Global FIS1 Antibody Market Size Growth Rate by Application, 2018 VS 2022 VS 2033 (US$ Million)
Figure 6. Global FIS1 Antibody Market Share by Application: 2022 VS 2033
Figure 7. Immunochemistry (IHC) Case Studies
Figure 8. Immunofluorescence (IF) Case Studies
Figure 9. Immunoprecipitation (IP) Case Studies
Figure 10. Western Blot (WB) Case Studies
Figure 11. ELISA Case Studies
Figure 12. Others Case Studies
Figure 13. FIS1 Antibody Report Years Considered
Figure 14. Global FIS1 Antibody Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global FIS1 Antibody Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global FIS1 Antibody Market Share by Region: 2022 VS 2033
Figure 17. Global FIS1 Antibody Market Share by Players in 2022
Figure 18. Global Top FIS1 Antibody Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in FIS1 Antibody as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by FIS1 Antibody Revenue in 2022
Figure 20. North America FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America FIS1 Antibody Market Share by Type (2018-2033)
Figure 22. North America FIS1 Antibody Market Share by Application (2018-2033)
Figure 23. North America FIS1 Antibody Market Share by Country (2018-2033)
Figure 24. United States FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Canada FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 26. Europe FIS1 Antibody Market Size YoY (2018-2033) & (US$ Million)
Figure 27. Europe FIS1 Antibody Market Share by Type (2018-2033)
Figure 28. Europe FIS1 Antibody Market Share by Application (2018-2033)
Figure 29. Europe FIS1 Antibody Market Share by Country (2018-2033)
Figure 30. Germany FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. France FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. U.K. FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Italy FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 34. Russia FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Nordic Countries FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. China FIS1 Antibody Market Size YoY (2018-2033) & (US$ Million)
Figure 37. China FIS1 Antibody Market Share by Type (2018-2033)
Figure 38. China FIS1 Antibody Market Share by Application (2018-2033)
Figure 39. Asia FIS1 Antibody Market Size YoY (2018-2033) & (US$ Million)
Figure 40. Asia FIS1 Antibody Market Share by Type (2018-2033)
Figure 41. Asia FIS1 Antibody Market Share by Application (2018-2033)
Figure 42. Asia FIS1 Antibody Market Share by Region (2018-2033)
Figure 43. Japan FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. South Korea FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. China Taiwan FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 46. Southeast Asia FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. India FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Australia FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America FIS1 Antibody Market Size YoY (2018-2033) & (US$ Million)
Figure 50. Middle East, Africa, and Latin America FIS1 Antibody Market Share by Type (2018-2033)
Figure 51. Middle East, Africa, and Latin America FIS1 Antibody Market Share by Application (2018-2033)
Figure 52. Middle East, Africa, and Latin America FIS1 Antibody Market Share by Country (2018-2033)
Figure 53. Brazil FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 54. Mexico FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 55. Turkey FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 56. Saudi Arabia FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 57. Israel FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 58. GCC Countries FIS1 Antibody Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 59. Merck Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 60. Bioss Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 61. Thermo Fisher Scientific Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 62. Novus Biologicals Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 63. GeneTex Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 64. Enzo Life Sciences, Inc. Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 65. RayBiotech Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 66. LifeSpan BioSciences Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 67. Leading Biology Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 68. ProSci Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 69. Abcam Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 70. OriGene Technologies Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 71. NSJ Bioreagents Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 72. Affinity Biosciences Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 73. Biobyt Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 74. Jingjie PTM BioLab Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 75. Beijing Solarbio Revenue Growth Rate in FIS1 Antibody Business (2018-2023)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries